Edge Medical Ventures

Edge Medical Ventures is a medtech-focused venture studio and fund managed by industry veterans with extensive operational experience. Their mission is to create or identify ventures that offer significant market opportunities by addressing critical clinical unmet needs through the development and investment in breakthrough medical device technologies. The firm operates a venture studio, EdgeLabs, designed to start from an unmet need posed by strategic collaborators, and a later-stage fund, EdgeMED, which typically invests in seed, Series A, and early Series B rounds, primarily at the clinical stage. Edge Medical Ventures is committed to advancing healthcare by identifying and nurturing innovative companies that address significant unmet clinical needs with substantial market potential. They are particularly dedicated to supporting Israeli MedTech companies looking to enter the U.S. market, leveraging strong connections with U.S.-based healthcare systems, investors, and industry leaders to bridge Israeli innovation with the U.S. healthcare system. This includes guidance in clinical operations, preparation for commercial launch, networking with leading U.S. healthcare systems, and establishing U.S.-based offices and personnel. Through their strong collaborations with strategic players, healthcare systems, and investors in the U.S., Edge is positioned to help Medtech ventures scale effectively. In 2025, Edge was selected by the Israel Innovation Authority as the only healthcare deep-tech fund in its new incubator program, receiving over $10 million in support to de-risk early-stage technologies before they face the global market. This designation underscores Edge's commitment to transforming healthcare through strategic investments in high-impact medical device companies. By combining financial investment with hands-on operational, clinical, and regulatory expertise, Edge Medical Ventures helps medtech startups scale breakthrough solutions into global impact. They also support healthcare providers in enhancing internal and open innovation, aiming to create companies that address the most pressing challenges in healthcare. Their focus areas include medical device and bio-convergence technologies that address real-world clinical challenges identified by physicians and strategic partners. Through this approach, Edge Medical Ventures continues to play a pivotal role in advancing healthcare innovation and supporting the growth of transformative medical technologies.